Curis, Inc. (CRIS), appoints Mani Mohindru, Ph.D., as Vice President of Corporate Strategy and Investor Relations
Oncology based company, Curis, Inc. (CRIS), announced earlier today the appointment of Dr. Mani Mohindru as Vice President of Corporate Strategy and Investor Relations. Dr. Mohindru, recruited for her expertise and experience supporting development and corporate strategy will direct product strategy, corporate development, investor relations and corporate communications. Curis, Inc. currently seeks to both develop and commercialize next generation targeted drug candidates for cancer treatment purposes. "Dr. Mohindru brings to Curis a strong and unique understanding of cancer drug markets and development strategies due to her wealth of experience in the analysis of the biotechnology sector," stated Mike Gray, Curis…